Palladium-Catalyzed Borylation of Aryl Chlorides: Scope, Applications, and Computational Studies
From chloride to boronate: Catalysts comprising palladium and biaryl monophosphine ligands provide highly active systems for the borylation of aryl and heteroaryl chlorides (see scheme). Symmetrical and unsymmetrical biaryl products can also be prepared directly from two aryl chlorides without isola...
Saved in:
Published in | Angewandte Chemie (International ed.) Vol. 46; no. 28; pp. 5359 - 5363 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Weinheim
Wiley-VCH Verlag
01.01.2007
WILEY-VCH Verlag WILEY‐VCH Verlag Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | From chloride to boronate: Catalysts comprising palladium and biaryl monophosphine ligands provide highly active systems for the borylation of aryl and heteroaryl chlorides (see scheme). Symmetrical and unsymmetrical biaryl products can also be prepared directly from two aryl chlorides without isolation of the intermediate boronate esters. Computational studies provide insight into the roles of the biaryl phosphine ligand and the KOAc base in the catalytic cycle. |
---|---|
Bibliography: | http://dx.doi.org/10.1002/anie.200701551 ark:/67375/WNG-BRC0PH60-B National Institutes of Health - No. GM 46059 NSF - No. CHE 9808061; No. DBI 9729592 Amgen Boehringer Ingelheim We thank the National Institutes of Health (GM 46059) for support of this work. We are grateful to Merck, Amgen, Boehringer Ingelheim, BASF (Pd(OAc)2), and Saltigo (XPhos) for additional support. The Varian NMR instruments used in this work were purchased with funding from the NSF (CHE 9808061 and DBI 9729592). istex:174713C225F61D6F2BBC271B1CF4F07F144FCCD3 Merck ArticleID:ANIE200701551 and Saltigo (XPhos) for additional support. The Varian NMR instruments used in this work were purchased with funding from the NSF (CHE 9808061 and DBI 9729592). 2 We thank the National Institutes of Health (GM 46059) for support of this work. We are grateful to Merck, Amgen, Boehringer Ingelheim, BASF (Pd(OAc) Medline NIH RePORTER ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1433-7851 1521-3773 |
DOI: | 10.1002/anie.200701551 |